Navigation Links
President Obama Meets U.S. Laureates of 2010 Kavli Prizes
Date:6/6/2011

WASHINGTON, June 6, 2011 /PRNewswire-USNewswire/ -- At the White House today, President Barack Obama met in the Oval Office with the seven U.S. recipients of the 2010 Kavli Prizes to recognize and honor their seminal contributions to the three fields for which the Prizes are awarded -- astrophysics, nanoscience and neuroscience.

(Photo: http://photos.prnewswire.com/prnh/20110606/DC14848)

Joined by the President's science advisor, John P. Holdren, President Obama greeted Kavli Prize Laureates Roger Angel (University of Arizona), Jerry E. Nelson (University of California, Santa Cruz), Donald M. Eigler (IBM Almaden Research Center), James E. Rothman (Yale University), Richard H. Scheller (Genentech), Nadrian C. Seeman (New York University), and Thomas C. Sudhof (Stanford University).  Accompanying the laureates were Fred Kavli, Founder and Chairman of The Kavli Foundation; Robert W. Conn, President of The Kavli Foundation; and Wegger Chr. Strommen, the Norwegian Ambassador to the United States.

The Kavli Prizes are a partnership between The Kavli Foundation (U.S.), the Norwegian Academy of Science and Letters and the Norwegian Ministry of Education and Research.

"We are extremely grateful to the President for the honor of this visit, and for his strong and heartfelt commitment to scientific research and discovery," said Fred Kavli. "It reflects the nation's deep support for innovative research that scientists across the country rely upon, including the foundational research discoveries of the 2010 Kavli Laureates."

The Kavli Laureates received their awards for research that made it possible to look more deeply and clearly into the universe, to control matter on the nano scale, and to understand how the brain's nerve cells communicate.

The 2010 Kavli Prize in Astrophysics was awarded to Roger Angel, Jerry E. Nelson and Raymond N. Wilson (European Souther
'/>"/>

SOURCE The Kavli Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AquaStar Holdings, Inc. Subsidiary Appoints Former Beckman Coulter Executive as Vice President of Operations
2. GeoVax Labs Announces Availability of 2010 Annual Report and Presidents Letter to Stockholders
3. ERT Announces Appointment of New President and CEO
4. Kevin Garrity Named President of HollisterStier Allergy
5. TEI Biosciences Chairman, President and CEO Yiannis Monovoukas Named Ernst & Young Entrepreneur Of The Year® 2011 New England Award Semifinalist
6. Stem Cell Assurance Announces Hiring of Vice President of Research and Development
7. The American Chamber of Commerce in Spain Awards the Global Business Leader Award 2011 to Victor Grifols Roura, President and CEO of Grifols
8. HumanTouch Founder, President and CEO, Moe Jafari Named Washington Business Journal Minority Business Leader Honoree
9. Access Pharmaceuticals Appoints Industry Executive Anthony Mottola as Vice President of Managed Care and Market Access
10. SeraCare Life Sciences Appoints Sean OConnor as Vice President of Sales and Marketing
11. Laureate Biopharma Appoints Ann M. Daus, Ph.D. Vice President, Quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... report expects global cell isolation and expansion market to ... carefully analyzed data about the vital drivers, restraints, trends, ... Copy of Report @ http://bit.ly/1yUxy0T , According ... will keep witnessing growth at an impressive CAGR during ... by rapid technological advancements, government funding and investments, and ...
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, ... focused on gynecologic disease, announced today that investors ... , Birchview Fund LLC and several Vermillion directors ... unregistered shares of Vermillion,s common stock and warrants ... in a private placement.  Under ...
(Date:12/24/2014)... , Dec. 23, 2014  Rock Creek Pharmaceuticals, ... it has filed a Clinical Trial Application (CTA) with ... products Regulatory Agency (MHRA) seeking regulatory approval to initiate ... molecule, Anatabine Citrate. Contingent on the Company ... a Phase I trial to assess the safety, tolerability ...
(Date:12/22/2014)... 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, ... today announced positive topline safety and tolerability ... of SYN-004, the Company,s investigational oral beta-lactamase ... difficile (C. difficile) infection, antibiotic-associated diarrhea ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... BEIJING, May 1 Sinovac Biotech Ltd. (NYSE Amex: ... in China, today announced that it has filed its Annual ... Commission for the year ended December 31, 2008 on May ... now available on the Company,s website under the investor relations ...
... of $79.7 Million, Increase of 29% over First Quarter 2008- ... per Diluted Share, Increases of 14% and 20% over First ... Therapeutics Corporation (Nasdaq: UTHR ) today announced its ... Total revenues for the first quarter of 2009 were ...
... Earnings Conference Call to be Held on May 15, ... / 8:00 pm (Beijing/Shanghai/Hong Kong)SHANGHAI, May 1 /PRNewswire-Asia/ -- ... a leading pharmaceutical, biotechnology and medical device R&D outsourcing ... today announced that it will release financial results for ...
Cached Biology Technology:Sinovac Biotech Ltd. Files Annual Report on Form 20-F 2United Therapeutics Reports First Quarter 2009 Financial Results 2United Therapeutics Reports First Quarter 2009 Financial Results 3United Therapeutics Reports First Quarter 2009 Financial Results 4United Therapeutics Reports First Quarter 2009 Financial Results 5United Therapeutics Reports First Quarter 2009 Financial Results 6United Therapeutics Reports First Quarter 2009 Financial Results 7WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release 2
(Date:12/19/2014)... 2014 Research and Markets ( ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... in July 2012, Apple introduced the fingerprint reading ... the only device of Apple incorporating such a ...
(Date:12/17/2014)... Dec. 15, 2014 The Defense Logistics ... easier to detect and prevent counterfeit microcircuits from ... the agency started performing an in-house microcircuit anti-counterfeit ... the authenticity of purchased microcircuits while increasing their ... control measures will be conducted at DLA,s Electronics ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... A - a potential agent of biological warfare and one ... able to sneak into cells. , The finding is ... paralytic illness caused by the toxin more commonly known as ... alleviate many medical problems, the recent work could help to ...
... found a common genetic variation in an immune system ... psoriasis ?a disfiguring inflammatory skin disease. , Named PSORS1 ... first genetic determinant of psoriasis to be definitively identified ... to new, more effective treatments for psoriasis without the ...
... that appear to play a significant role in the ... ability to form clots following an injury. They also ... may contribute to certain forms of leukemia. , "Basically, ... are turned off in normal platelet development, but turned ...
Cached Biology News:Scientists reveal how deadly toxin hijacks cells 2U-M scientists identify major psoriasis susceptibility gene 2U-M scientists identify major psoriasis susceptibility gene 3U-M scientists identify major psoriasis susceptibility gene 4MiRNA fingerprint identified in platelet formation 2
... Source: Streptomycin verticillus USBio Analyzed PRODUCT SPECIFICATIONS Form: White powder ... pH (10 units/ml): 4.5 to 6.0 Loss On Drying: less ... equal to 0.1% Bleomycin Content: A 2 : 55 - ... B 2 : greater than or equal to 90% B ...
6 x Blend of rTth DNA Polymerase and Tli to provide optimized amounts of both 5-3 and 3-5 proofreading activity...
Economical and manually filled LN2 vacuum insulated storage container offers high capacity and low nitrogen consumption while offering convenient storage of samples....
... (8-iso-13,14-dihydro-15-keto PGF2α) is a metabolite of ... rabbits, monkeys and humans. 8-iso PGF2α ... lipid peroxidation. In both humans and ... primarily to metabolites having 2 or ...
Biology Products: